metsera glp 1 Healthy Returns: Pfizer's new obesity bet, Metsera, releases drug data Pfizer sues Novo Nordisk and

Blood glucose testing may show whether hyperglycemia is part of the picture, while the physical exam and vital signs help show urgency

Not just to function, but to thrive

Eating smaller, more frequent meals and avoiding high-fat or spicy foods can reduce nausea

Just based on two high level metrics when it was removed from the shortage list (based on pharmacy supply calls and patients pick up rates here at Ro): Pharmacy Supply Calls: 38% of pharmacies have stock 15% do not have stock but expect to have it in the future 48% say its on back order and materially less supply than other Wegovy doses Patient pick up rates: 30-35% are able to find supply in 14 days 65-70% are able to find supply in 30 days If providers are using the FDAs list to determine what path to recommend for their patients, we need to ensure the FDA has as much information as possible to make that determination

Ethics statement The animal study was reviewed and approved by First Affiliated Hospital of Harbin Medical University

Addressing obesity has become both a critical focus and a persistent challenge in medical research